Powder: -20°C for 3 years | In solvent: -80°C for 1 year
R306465 is a potent inhibitor of HDAC1 and -8 (class I) in vitro. It potently inhibited cell proliferation of all main solid tumour indications, including colon, ovarian, breast, lung and prostate cancer cell lines with IC50 values ranging from 30 to 300 nM.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
25 mg | 6-8 weeks | $ 1,520.00 | |
50 mg | 6-8 weeks | $ 1,980.00 | |
100 mg | 6-8 weeks | $ 2,500.00 |
Description | R306465 is a potent inhibitor of HDAC1 and -8 (class I) in vitro. It potently inhibited cell proliferation of all main solid tumour indications, including colon, ovarian, breast, lung and prostate cancer cell lines with IC50 values ranging from 30 to 300 nM. |
Synonyms | R-306465, JNJ 16241199, R 306465, JNJ-16241199, JNJ16241199 |
Molecular Weight | 413.45 |
Formula | C19H19N5O4S |
CAS No. | 604769-01-9 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: Soluble
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
R306465 604769-01-9 R-306465 JNJ 16241199 R 306465 JNJ-16241199 JNJ16241199 inhibitor inhibit